Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal butorphanol for painless gastroenteroscopy
ChiCTR2100048028Phase 4Not yet recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of butorphanol, sufentanil and propofol (3 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: Dose of propofol. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
butorphanolsufentanilpropofol
Beyond the preview
Go deeper on ChiCTR2100048028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048028.